Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -258,131 | -325,104 | -277,417 | -173,910 | -45,574 |
| Depreciation Amortization | 3,468 | 1,667 | 765 | 490 | 349 |
| Accounts receivable | -40,308 | -5,930 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,604 | -196 | 4,168 | 2,074 | -1,304 |
| Other Working Capital | -37,861 | -583 | 38,103 | 5,118 | 1,346 |
| Other Operating Activity | 152,629 | 107,351 | 72,818 | 38,351 | 12,992 |
| Operating Cash Flow | $-175,599 | $-222,795 | $-161,563 | $-127,877 | $-32,191 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,451 | -7,385 | -10,196 | -2,016 | -642 |
| Purchase Of Investment | -293,336 | -578,524 | -485,250 | -305,423 | -446,190 |
| Sale Of Investment | 378,582 | 620,663 | 279,849 | 391,031 | 28,000 |
| Purchase Sale Intangibles | -16,250 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -16,250 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $64,545 | $34,754 | $-215,597 | $83,592 | $-418,832 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,201 | 139 | 57,431 | 1,157 | 893 |
| Common Stock Repurchased | -8,438 | -2,800 | -1,341 | N/A | N/A |
| Other Financing Activity | 0 | 299,300 | 284,612 | 0 | 269,592 |
| Financing Cash Flow | $4,763 | $296,639 | $340,702 | $1,157 | $270,485 |
| Beginning Cash Position | 176,666 | 68,068 | 104,526 | 147,654 | 328,192 |
| End Cash Position | 70,375 | 176,666 | 68,068 | 104,526 | 147,654 |
| Net Cash Flow | $-106,291 | $108,598 | $-36,458 | $-43,128 | $-180,538 |
| Free Cash Flow | |||||
| Operating Cash Flow | -175,599 | -222,795 | -161,563 | -127,877 | -32,191 |
| Capital Expenditure | -4,451 | -7,385 | -10,196 | -2,016 | -642 |
| Free Cash Flow | -180,050 | -230,180 | -171,759 | -129,893 | -32,833 |